STOCK TITAN

CorVel Announces Revenues and Earnings  

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CorVel Corporation (NASDAQ: CRVL) reported Q2 earnings of 65 cents per share with revenues of $136 million, and year-to-date revenues of $266 million. Despite ongoing global economic uncertainty, the company exhibited strong fundamentals with robust new business sales. The pandemic has accelerated technology adoption, enhancing CorVel's digital strategy and leading to a significant rise in telehealth usage. Strategic partnerships in the healthcare sector are expected to improve payment operations and reduce costs.

Positive
  • Q2 earnings per share of 65 cents, with revenues of $136 million.
  • Year-to-date revenues of $266 million, indicating strong growth.
  • Significant increase in telehealth usage contributing to better outcomes.
  • Strategic partnerships cover one-third of U.S. insured lives, enhancing payment integrity.
Negative
  • None.

IRVINE, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced its results for the quarter ended September 30, 2020. Earnings per share for the quarter ended September 30, 2020 were 65 cents. Revenues for the period were $136 million. Earnings per share for the six months ended September 30, 2020 were $1.11 and revenues for the six months ended September 30, 2020 were $266 million.

While global economic uncertainty remains, CorVel’s business fundamentals are sound and performed well during the quarter. In conjunction with robust year-to-date sales of new business, adjustments made to operational parameters in response to the pandemic contributed to strong cash flows.

The pandemic has accelerated adoption of new technology and driven the Company’s digital strategy forward. CorVel was the first third-party administrator (TPA) to introduce a patient advocacy model coupled with telehealth more than five years ago. Over these last six months, CorVel has seen an exponential increase in telehealth usage, with a corresponding improvement in results achieved.

The broader healthcare market continues to be important to CorVel’s overall results and future plans. While the healthcare market has experienced consolidation and a move towards internalizing payment integrity functions, CERiS has forged several additional long-term partnerships covering one-third of the covered lives in the U.S. These strategic alliances improve healthcare payment operations through innovative technology and generate cost savings by identifying and reducing inappropriate spending.

About CorVel  

CorVel Corporation is a national provider of innovative workers’ compensation, auto, liability and health solutions for employers, third party administrators, insurance companies, and government agencies seeking to control costs and promote positive outcomes. We apply technology, intelligence, and a human touch throughout the risk management process so our clients can intervene early and often while being connected to the critical intelligence they need to proactively manage risk. With a robust technology platform at its core, our connected solution is delivered by a national team of associates who are committed to helping clients design and administer programs that meet their organization’s performance goals.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

All statements included in this press release, other than statements or characterizations of historical fact, are forward-looking statements. These forward-looking statements are based on the Company’s current expectations, estimates and projections about the Company, management’s beliefs, and certain assumptions made by the Company, and events beyond the Company’s control, all of which are subject to change. Such forward-looking statements include, but are not limited to, statements relating to the Company’s telehealth services and the Company’s continued investment in these and other innovative technologies, and statements relating to the Company’s strategic alliances within the healthcare market. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause the Company’s actual results to differ materially and adversely from those expressed in any forward-looking statement, including the risk that the impact of the COVID-19 pandemic on our business, results of operations and financial condition is greater than our initial assessment.

The risks and uncertainties referred to above include but are not limited to factors described in this press release and the Company’s filings with the Securities and Exchange Commission, including but not limited to “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2020 and the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020. The forward-looking statements in this press release speak only as of the date they are made. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason.


CorVel Corporation
Quarterly Results – Income Statement
Quarters and Six Months Ended September 30, 2020 (unaudited) and September 30, 2019 (unaudited)

Quarter Ended September 30, 2020  September 30, 2019 
Revenues $136,028,000  $146,970,000 
Cost of revenues  105,525,000   114,127,000 
Gross profit  30,503,000   32,843,000 
General and administrative  15,560,000   16,593,000 
Income from operations  14,943,000   16,250,000 
Income tax provision  3,078,000   3,379,000 
Net income $11,865,000  $12,871,000 
Earnings Per Share:        
Basic $0.66  $0.70 
Diluted $0.65  $0.69 
Weighted Shares        
Basic  17,937,000   18,452,000 
Diluted  18,174,000   18,771,000 


Six Months Ended September 30, 2020  September 30, 2019 
Revenues $265,628,000  $297,109,000 
Cost of revenues  208,616,000   231,132,000 
Gross profit  57,012,000   65,977,000 
General and administrative  31,145,000   32,345,000 
Income from operations  25,867,000   33,632,000 
Income tax provision  5,700,000   7,354,000 
Net income $20,167,000  $26,278,000 
Earnings Per Share:        
Basic $1.12  $1.42 
Diluted $1.11  $1.40 
Weighted Shares        
Basic  17,960,000   18,488,000 
Diluted  18,144,000   18,779,000 

CorVel Corporation
Quarterly Results – Condensed Balance Sheet
September 30, 2020 (unaudited) and March 31, 2020 (audited)

  September 30, 2020  March 31, 2020 
Cash $106,082,000  $83,223,000 
Customer deposits  52,570,000   48,991,000 
Accounts receivable, net  73,095,000   65,767,000 
Prepaid taxes and expenses  10,561,000   11,010,000 
Property, net  71,980,000   75,900,000 
Goodwill and other assets  39,792,000   40,703,000 
Right-of-use asset, net  87,500,000   90,666,000 
Total $441,580,000  $416,260,000 
Accounts and taxes payable $13,309,000  $16,363,000 
Accrued liabilities  135,768,000   117,326,000 
Deferred tax liability  7,205,000   7,764,000 
Long-term operating lease liabilities  82,898,000   85,096,000 
Paid-in capital  175,900,000   168,938,000 
Treasury stock  (546,204,000)  (531,764,000)
Retained earnings  572,704,000   552,537,000 
Total $441,580,000  $416,260,000 

 


Contact: Melissa Storan
Phone: 949-851-1473
http://www.corvel.com

FAQ

What were CorVel's earnings per share for Q2 2020?

CorVel's earnings per share for Q2 2020 were 65 cents.

How much revenue did CorVel report for the quarter ended September 30, 2020?

CorVel reported revenues of $136 million for the quarter ended September 30, 2020.

What is the total revenue CorVel reported for the first six months of 2020?

CorVel reported total revenues of $266 million for the first six months of 2020.

How has the pandemic affected CorVel's business operations?

The pandemic has accelerated the adoption of new technology and enhanced CorVel's digital strategy.

What strategic partnerships has CorVel formed recently?

CorVel has forged several long-term partnerships in healthcare, covering one-third of insured lives in the U.S.

Corvel Corp

NASDAQ:CRVL

CRVL Rankings

CRVL Latest News

CRVL Stock Data

5.74B
9.17M
46.43%
54.45%
2.27%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States of America
IRVINE